World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
125
Citations
97449
World Ranking
3011
National Ranking
123

Overview

Fred Saad is affiliated with the University of Montreal in Canada and has a significant research presence in the medical field, particularly focused on prostate cancer. Their work is concentrated within the broader discipline of Medicine, with specialized contributions in Pulmonary and Respiratory Medicine, Surgery, Oncology, Radiology, Nuclear Medicine and Imaging, and Cancer Research.

Their research topics cover a variety of cancer treatments and studies, with prominent emphasis on:

  • Prostate Cancer Treatment and Research
  • Prostate Cancer Diagnosis and Treatment
  • Bladder and Urothelial Cancer Treatments
  • Radiopharmaceutical Chemistry and Applications
  • Urinary and Genital Oncology Studies
  • Cancer, Lipids, and Metabolism
  • Renal cell carcinoma treatment

Fred Saad has co-authored extensively with collaborators such as Zhe Tian, Alberto Briganti, Pierre I. Karakiewicz, Felix K.-H. Chun, and Shahrokh F. Shariat, reflecting a collaborative research network.

Their frequent publication venues highlight engagement with clinical and oncological audiences. These venues include:

  • Journal of Clinical Oncology
  • The Journal of Urology
  • European Urology
  • Urologic Oncology Seminars and Original Investigations
  • Clinical Genitourinary Cancer

Selected recent papers by Fred Saad's group demonstrate involvement with key developments in prostate cancer therapies and management. Notable publications include:

  • Olaparib for Metastatic Castration-Resistant Prostate Cancer, 2020, New England Journal of Medicine
  • Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer, 2020, New England Journal of Medicine
  • Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer, 2020, New England Journal of Medicine
  • Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer, 2020, New England Journal of Medicine
  • Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019, 2020, European Urology

Best Publications

  • Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

    Howard I. Scher;Karim Fizazi;Fred Saad;Mary-Ellen Taplin

  • Abiraterone and Increased Survival in Metastatic Prostate Cancer

    Johann S. de Bono;Christopher J. Logothetis;Arturo Molina;Karim Fizazi

  • Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

    Tomasz M Beer;Andrew J Armstrong;Dana E Rathkopf;Yohann Loriot

  • Oncogenic Signaling Pathways in The Cancer Genome Atlas

    Francisco Sanchez-Vega;Marco Mina;Joshua Armenia;Walid K. Chatila

  • Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy

    Charles J. Ryan;Matthew R. Smith;Johann S. De Bono;Arturo Molina

  • The Molecular Taxonomy of Primary Prostate Cancer

    Adam Abeshouse;Jaeil Ahn;Rehan Akbani;Adrian Ally

  • Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

    Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf

  • Comprehensive Characterization of Cancer Driver Genes and Mutations.

    Matthew H Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • A Randomized, Placebo-Controlled Trial of Zoledronic Acid in Patients With Hormone-Refractory Metastatic Prostate Carcinoma

    Fred Saad;Donald M. Gleason;Robin Murray;Simon Tchekmedyian

  • Olaparib for metastatic castration-resistant prostate cancer

    Johann de Bono;Joaquin Mateo;Karim Fizazi;Fred Saad

  • Long-Term Efficacy of Zoledronic Acid for the Prevention of Skeletal Complications in Patients With Metastatic Hormone-Refractory Prostate Cancer

    Fred Saad;Donald M. Gleason;Robin Murray;Simon Tchekmedyian

  • Denosumab in men receiving androgen-deprivation therapy for prostate cancer

    Matthew R. Smith;Blair Egerdie;Narciso Hernández Toriz;Robert Feldman

  • Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer

    Matthew R Smith;Fred Saad;Simon Chowdhury;Stéphane Oudard

  • Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study

    Karim Fizazi;Howard I. Scher;Arturo Molina;Christopher J. Logothetis

  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy

    Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao

  • Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study

    Charles J. Ryan;Matthew R. Smith;Karim Fizazi;Fred Saad

  • Enzalutamide in men with nonmetastatic, castration-resistant prostate cancer

    Maha Hussain;Karim Fizazi;Fred Saad;Per Rathenborg

  • Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer : results of a phase 3, randomised, placebo-controlled trial.

    Matthew R Smith;Fred Saad;Robert Coleman;Neal Shore

  • Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases

    F. Saad;J. E. Brown;C. Van Poznak;T. Ibrahim

  • The Molecular Taxonomy of Primary Prostate Cancer

    Adam Abeshouse;Jaeil Ahn;Rehan Akbani;Adrian Ally

Frequent Co-Authors

Pierre I. Karakiewicz
Pierre I. Karakiewicz University of Montreal
Shahrokh F. Shariat
Shahrokh F. Shariat Medical University of Vienna
Alberto Briganti
Alberto Briganti Vita-Salute San Raffaele University
Markus Graefen
Markus Graefen Universität Hamburg
Francesco Montorsi
Francesco Montorsi Vita-Salute San Raffaele University
Karim Fizazi
Karim Fizazi University of Paris-Saclay
Matthew R. Smith
Matthew R. Smith Harvard University
Cora N. Sternberg
Cora N. Sternberg Cornell University
Anne-Marie Mes-Masson
Anne-Marie Mes-Masson University of Montreal
Neal D. Shore
Neal D. Shore Carolina Urologic Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring related online degrees can open new pathways for those interested in Medicine or healthcare careers in the USA. A popular choice is a degree in healthcare administration, which equips students to manage healthcare organizations, clinics, or hospital departments. These programs often emphasize leadership, policy analysis, and healthcare systems.

Nurses seeking to advance their qualifications may consider adn to np programs online, which provide a streamlined pathway for registered nurses to become nurse practitioners. These bridge programs offer flexibility for working professionals, allowing them to gain new clinical skills and expanded scope of practice.

For those drawn to preventive health, an online nutritionist degree prepares graduates to advise individuals and communities on diet, wellness, and disease prevention—skills highly valued in public health settings.

When choosing a healthcare program, use resources on how to evaluate healthcare administration degree programs. Checking program accreditation, curriculum relevance, and graduation outcomes can help ensure that your education aligns with career goals in the evolving healthcare landscape.

Best Scientists Citing Fred Saad

Trending Scientists